Advicenne Quote - ALDVI

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.05

Bid

2.03

Ask

2.05

Volume

9,944

1.966 Day's Range 2.05

0.827 52 Week Range 3.08

Market Cap

20.364M

Previous Close

2.03

Open

2.03

Last Trade

2.05

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

53,412

Shares Outstanding

9,933,732

Dividend Yield

PE Ratio

-2.90

Earnings Per Share (EPS)

-0.71

Revenue

3.48M

Net Profit

-7.03M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.advicenne.com

Headquarters

Paris, Paris, Fra

Founded

Advicenne is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALDVI. The last closing price for Advicenne was 2.03 €. Over the last year, Advicenne shares have traded in a share price range of 0.827 € to 3.08 €.

Advicenne currently has 9,933,732 shares outstanding. The market capitalization of Advicenne is 20.17 € million. Advicenne has a price to earnings ratio (PE ratio) of -2.90.

Advicenne Announces its 2025 Financial Calendar

Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those...

FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria.

After distal Renal Tubular Acidosis (dRTA) in December 2022, ADV7103 is granted "orphan drug" status in the United States in cystinuria. A long-awaited milestone for the Company and its...

Advicenne annonce les résultats de son augmentation de capital avec maintien du droit préférentiel de souscription

Souscription à hauteur de 5,7 M€ représentant 95% du montant initial Cemag Invest et Bpifrance détiennent respectivement 18,0% et 21,6% du capital et 17,6% et 23,6% des droits de vote ...

Advicenne : Lancement d’une augmentation de capital avec maintien du droit préférentiel de souscription afin d’accélérer la croissance en Europe et d’optimiser le développement clinique de ADV7103

Augmentation de capital avec maintien du droit préférentiel de souscription (le “DPS”) d’un montant initial de 6,0 M€, pouvant être porté à 6,9 M€ en cas d’exercice intégral de la clause...

Advicenne annonce le lancement de Sibnayal® au Danemark

Sibnayal® (citrate de potassium / bicarbonate de potassium) commercialisé depuis le 1er Mars 2023 Le prix de référence correspond à un coût de traitement annuel de 15.000 euros par patient...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	0.985221674877	2.03	2.15	1.9	25433	2.0477423	DE
4	-0.13	-5.96330275229	2.18	2.22	1.9	21306	2.09105024	DE
12	0.884	75.8147512864	1.166	2.39	0.85	53412	1.82292907	DE
26	-0.76	-27.0462633452	2.81	2.9	0.827	41354	1.71433423	DE
52	0.22	12.0218579235	1.83	3.08	0.827	45010	1.86048465	DE
156	-4.45	-68.4615384615	6.5	6.8	0.827	27852	2.80296927	DE
260	-4.45	-68.4615384615	6.5	6.8	0.827	27852	2.80296927	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALCYBCybergun	0.0002 € (100.00%)	10.06M
ALVETEGEIRO Pharma	0.124 € (58.97%)	481.8k
ALDVAlliance Developpement Capital Siic	0.074 € (32.14%)	6k
MLSRPSpeed Rabbit Pizza	8.20 € (30.16%)	19
MLSEQSequa Petroleum NV	0.011 € (29.41%)	12k
MLCOTCoretech 5	0.01 € (-41.18%)	200
ATOAtos SE	0.495 € (-32.65%)	17.92M
AFMEAffluent Medical	1.20 € (-21.05%)	21.92k
ALBIOBiosynex	2.095 € (-18.32%)	26.9k
TRACTTeract SA	1.03 € (-15.23%)	76.91k
BCPBanco Comercial Portugues SA	0.4457 € (2.20%)	44.64M
ALNEVNeovacs	0.0003 € (0.00%)	33.59M
ATOAtos SE	0.495 € (-32.65%)	17.92M
ALCYBCybergun	0.0002 € (100.00%)	10.06M
ORAOrange.	9.706 € (-2.99%)	9.65M